John C Reed Johnson & Johnson (JNJ) insider trading activity
John C Reed is EVP, Innovative Medicine, R&D of JOHNSON & JOHNSON. Currently has a direct ownership of 11,577 shares of JNJ, which is worth approximately $1.68 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 10,984 shares (Common Stock) at a price of $144.59 per share, resulting in proceeds of $1,588,176. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
11.6K
0%
3M change
n/a
12M change
Total Value Held
$1.68 Million
JOHN C REED Transaction History
JCR
John C Reed
EVP, Innovative Medicine, R&D
New Brunswick, NJ